This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Zhaoke (Guangzhou) Ophthalmic Drug Company Limited. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guangzhou, CN (2021)
- Hong Kong, CN (2021 - 2022)
Company Filing History:
Years Active: 2021-2022
Title: Innovations by Xiaoyi Li in Ophthalmic Drug Development
Introduction
Xiaoyi Li is a notable inventor based in Hong Kong, CN, recognized for his contributions to the field of ophthalmic drug development. He holds a total of 3 patents, showcasing his innovative approach to medical treatments.
Latest Patents
One of his latest patents is a treatment process for cyclosporine eye gel. This process involves several steps, including the addition of carbomer to water, thorough stirring, and homogenization. After preparing the carbomer base, it undergoes moist heat sterilization and vacuum degassing. The pH of the base is adjusted to between 5.0 and 9.0 using filtered sodium hydroxide solution. The final mixture includes polyoxyl 35 castor oil, cyclosporin A raw material, 1,2-propanediol, and water, which is prepared into a clear solution and filtered. This innovative process facilitates industrial production by performing sterilization and filtration before adding carbomer.
Another significant patent by Xiaoyi Li is a dispersion process for adapalene in gel preparation. This process includes pulverizing the adapalene raw material to specific particle sizes and creating a uniform jelly matrix by heating and stirring. The preparation demonstrates excellent emulsifying and dispersing effects of adapalene, making it suitable for large-scale industrial application.
Career Highlights
Xiaoyi Li is currently employed at Zhaoke (Guangzhou) Ophthalmic Drug Company Limited, where he continues to advance his research and development efforts in ophthalmic treatments. His work has significantly impacted the field, particularly in the formulation of effective drug delivery systems.
Collaborations
Xiaoyi Li collaborates with esteemed colleagues, including Gang Li and Xiangrong Dai, to further enhance the development of innovative ophthalmic solutions.
Conclusion
Xiaoyi Li's contributions to ophthalmic drug development through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile